783284-48-0

Basic information

• Product Name: Ethanesulfonic acid, 2-[(1-oxodocosyl)amino]-
• Synonyms: N-Docosanoyl Taurine;SAIMYQVCHHQQMU-UHFFFAOYSA-N;Ethanesulfonic acid, 2-[(1-oxodocosyl)amino]-
• CAS NO: 783284-48-0
• Molecular Formula: C24H49NO4S
• Molecular Weight: 447.72
• Mol File: 783284-48-0.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Ethanesulfonic acid, 2-[(1-oxodocosyl)amino]-(CAS DataBase Reference)
• NIST Chemistry Reference: Ethanesulfonic acid, 2-[(1-oxodocosyl)amino]-(783284-48-0)
• EPA Substance Registry System: Ethanesulfonic acid, 2-[(1-oxodocosyl)amino]-(783284-48-0)

Safety Data

• Hazardous Substances Data: 783284-48-0(Hazardous Substances Data)

Usage

Description

Ethanesulfonic acid, 2-[(1-oxodocosyl)amino]-, also known as N-Docosanoyl Taurine, is a synthetic organic compound with a unique structure that features a long-chain fatty acid amide linked to an ethane sulfonic acid group. Ethanesulfonic acid, 2-[(1-oxodocosyl)amino]exhibits properties that make it a versatile molecule with potential applications in various fields.

Uses

Used in Pharmaceutical Industry:
Ethanesulfonic acid, 2-[(1-oxodocosyl)amino]-, is used as a modulator of calcium channels for the treatment of various diseases. Its ability to activate multiple members of the transient receptor potential (TRP) family of calcium channels, including TRPV1 and TRPV4, which are expressed in the kidney, makes it a promising candidate for therapeutic applications. This activation can lead to the regulation of cellular processes and the potential treatment of conditions related to calcium channel dysfunction.
Used in Research Applications:
In the field of scientific research, Ethanesulfonic acid, 2-[(1-oxodocosyl)amino]-, can be utilized as a research tool to study the function and regulation of TRP channels. By investigating the effects of this compound on TRP channel activity, researchers can gain insights into the underlying mechanisms of calcium signaling and its role in various physiological and pathological processes.
Used in Drug Development:
Ethanesulfonic acid, 2-[(1-oxodocosyl)amino]-, has the potential to be developed into a drug candidate for the treatment of diseases associated with TRP channel dysfunction. Its unique structure and ability to modulate calcium channels make it a valuable starting point for the design and synthesis of new therapeutic agents. Further research and development efforts can lead to the optimization of this compound for specific therapeutic applications and the improvement of its pharmacological properties.